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impairment with a mean DLQI total scores of 4.0. Men and
women mean total scores were respectively: 2.7 vs. 4.9 (p <
0.05). The mean number of impacts was 2.3, patients were allo-
cated according to the number of impacts. For patients with
three impacts and less the mean DLQI total score was 3.3; it was
6.8 for patients with 4 impacts or more (p > 0.0001). The
patient’s perception of their sun sensitivity had a very strong
impact on patients’ QoL, the more sensitive, the more QoL was
impaired (p < 0.005). The use of sunscreen has an impact on
QoL the more patients use sunscreen, the better their QoL was
(p < 0.0005). All the symptoms associated with the sunburn
impaired the QoL (p < 0.05) except the skin peeling. Further
analysis demonstrated that age was not interacting with the
scores, neither was the activity when the sunburn occurs. CON-
CLUSIONS: Our population reﬂect a QoL impairment com-
pared to the ranges obtained when initially validating the DLQI;
i.e. for patients suffering acne the DLQI mean score was 4.3, it
was 6.7 for patients with viral wart and 3.4 for patients with
solar keratosis. Those results conﬁrm the ones obtained during
a previous study among pharmacy’s staff demonstrating a link
between QoL impairment and sunburns severity.
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Hair loss due to either ageing, pathology or drug therapy often
proves to be poorly accepted by those who suffer from it.
OBJECTIVES: To evaluate the quality impact of hair loss among
a representative sample of the French population. METHODS:
We questioned a representative sample of the entire French pop-
ulation aged 15 years and above. The sample was selected by
IPSOS Santé, using the method of quotas (sex, age, profession of
the head of the household) with simultaneous stratiﬁcation on
the basis of region / type of urban area. Interviews were sys-
tematically controlled by recalling 20% of those interviewed.
The SF-12 is a generic measure of health status. The SF-12 is
composed of two dimensions, a Physical Component Summary
(PCS-12) and a Mental component Summary (MCS-12). The
results are standardised on the general US population [mean
score of 50 (SD = 10)], so results can be meaningfully compared
to an average and compared one another. RESULTS: For men
suffering hair loss, the physical dimension is impaired (PCS-12:
48.57 vs. 49.22, p < 0.001), whereas for women, it is the mental
dimension which is impaired (MCS-12: 44.26 vs. 46.83, p <
0.001). The SF-12 seems to be an efﬁcient tool to asses the
quality of life of patients suffering hair loss, e.g. among patients
who expressed living it as a disability or an embarrassment, the
mental dimension was more impaired (PCS-12: 41.85 vs. 46.6,
p < 0.001). In total, 70% of women and 89% of men suffering
hair loss have never been treated whereas they consider it as a
dermatological disease for 38.4% and 25.6% respectively. There
was no differences concerning socio-demographic proﬁle and
hair loss. CONCLUSIONS: Concerning quality of life, assessed
by the SF-12, it demonstrated an impairment for patients suf-
fering hair loss, the altered dimensions are different for men and
women.
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OBJECTIVES: To evaluate the prevalence of hair loss among a
representative sample of the French population. METHODS: We
questioned a representative sample of the entire French popula-
tion aged 15 years and above. The sample was selected by IPSOS
Santé, using the method of quotas (sex, age, profession of the
head of the household). Interviews were systematically con-
trolled by recalling 20% of those interviewed. Hence, the sample
was set up in such a way that the results could be analyzed
without hesitation, particularly since the principles of statistical
representativeness were observed. RESULTS: Of the French pop-
ulation aged over 15 years interviewed in this survey (n = 1006),
40.3% declare suffering from hair loss (36.86% of men and
43.60% of women) and 3.9% are bald. More women that men
felt that their hair loss is important (8.8% vs. 8.7%) nor slightly
important (34.8% vs. 28.2%) but very few women were bald
(1.0% vs. 7.0%). No signiﬁcant difference was found in terms
of gender, socio-professional status, geographic localization nor
education level and their impact on hair loss. Mean age was dif-
ferent for patients suffering hair loss (47.6 vs. 43.6, p = 0.0008).
If 14.2% of women aged 15 to 19 years reported hair loss, only
3.4% of men did. Whereas 44% of men between 25 and 45
declared hair loss vs. 32 for women; over 60 years: 5% of men
versus 11% suffered from it. Among our population suffering
hair loss, 5.1% of them (male: 2.6% vs. female: 6.9%) consider
it as a disability or embarrassment in their professional life,
whereas they are 17.4% (male: 8.8% vs. female: 24.1%) to con-
sider it as a disability or embarrassment in their personal life.
CONCLUSIONS: Hair loss concern an important population
among young women, therefore its management by dermatolo-
gists is justiﬁed.
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OBJECTIVES: The ICARE programme’s objective is to asses
patients’ knowledge of the consequences of sun exposure. Its
speciﬁcity and relevance are based on the fact that patients were
asked to ﬁll in a questionnaire after a sunburn. METHODS:
Every patient coming to an outpatient pharmacy in order to
obtain advice or treatment following a sunburn was remitted a
questionnaire assessing their knowledge of the consequences of
sun exposure. RESULTS: Three populations were identiﬁed.
Those who perceive themselves as having a high sun sensitivity,
a sun sensitivity and those who estimate having a low sun sen-
sitivity. In our population, 36% expose themselves more than 2
hours a day, 51% between 11.00–16.00, 76% do it after 16.00
and 36% before 11.00. A total of 35% applied regular protec-
tive skin lotion and 44% protect themselves from the sun with
a cloth. The patient’s perception of their sun sensitivity had a
very strong impact on patients’ QoL, the more sensitive, the
more QoL was impaired (p < 0.005). The perception patients
have of their sun sensitivity is correlated with their skin type and
their sunburn history. Patients with sensitive skin are aware of
their personal skin status and require more professional advice
when buying protective skin lotions (58%) vs. normal skin
(38%). Forty-two percent (42%) of patients with normal skin
buy protective skin lotions in supermarkets and if 71% of the
population with sensitive skin buy protective skin lotions with a
protection factor over 20, only 59% of the population with
normal skin do so. CONCLUSIONS: Efforts realised by profes-
sionals (dermatologists, pharmacists and GP’s) in the past years
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are starting to bear fruit. Patients with high sun sensitivity
manage to better protect themselves from sun exposure but,
despite this, there is a strong need to reinforce sun exposure risk
awareness in the general population.
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OBJECTIVES: To examine the literature on impacted cerumen
with speciﬁc reference to pharmacological ceruminolytic agents,
its epidemiology and current management in primary care.
METHODS: A systematic literature review was undertaken by
an electronic search of the Medline, Embase, Health Star,
Current Contents, NHSEED and Cochrane databases. The
search terms for the database included “cerumen”, “ear wax”
and “hearing loss” and included papers published between
January 1, 1990 and July 31, 2002. RESULTS: Impacted
cerumen is commonly seen in primary care settings. Between 1.2
million and 3.5 million people in the UK suffer from impacted
cerumen. Moreover, 2.3 million people in the UK suffer cerumen
problems serious enough to warrant management, with approx-
imately four million ears being syringed annually. Impacted
cerumen causes unpleasant symptoms and is occasionally asso-
ciated with serious sequale, such as hearing loss, social with-
drawal, poor work function and perforated eardrums. The
physiology, clinical signiﬁcance and management implications
associated with excessive and impacted cerumen remain poorly
characterised. The evidence supporting the traditional view that
cerumen plays a biologically or clinically signiﬁcant role in host
defence is weak; rather the consensus seems to be that if any-
thing, cerumen offers a rich medium supporting microbiological
growth. CONCLUSIONS: Patients with impacted cerumen
clearly require effective treatment. However, given a dearth of
rigorous evidence in the literature any attempt at a systematic
assessment of optimal management strategies is exceedingly dif-
ﬁcult. The evidence surrounding the pharmacological manage-
ment of impacted cerumen is inconsistent and few conclusions
can be drawn. There is clearly a need for a deﬁnitive assessment
of the most effective pharmacological strategy for cerumen
removal. Lastly, the causes and management of impacted
cerumen require further investigation.
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OBJECTIVES: Investigate whether methods employed to reduce
omitted variable bias can be used in a cross-sectional database
to identify a relationship between supplemental vitamin usage
and the presence of Age-related Macular Degeneration (AMD)
in a Latino population. METHODS: Data were obtained from
the Los Angeles Latino Eye Study (LALES) and included 6104
subjects. Data were originally collected to assess the prevalence
of ocular disease and diabetes. Stepwise logistic regressions and
simple logistic regressions for AMD were performed. Propensity
scores were then used to control for selection bias. In the ﬁrst
stage, the probability of receiving vitamin supplements for 10
years or more was modeled using logistic regression. Subjects
were separated into quintiles deﬁned by their propensity scores
and we compared the vitamin supplement/no vitamin supple-
ment groups using a 2-way analysis of variance model. Finally,
the effect of vitamin use on AMD after selection bias adjustment
was estimated using logistic regression. RESULTS: In total, 572
cases of AMD were identiﬁed. When using stepwise logistic
regression, older subjects (OR: 1.043, CI: 1.034–1.052), males
(1.624, 1.157–2.280), and people with income level less than
$20,000 (1.428, 1.006–2.028) were more likely to develop
AMD. Only age and gender were signiﬁcant using logistic regres-
sion and adjusting for potential confounders. The seven covari-
ates found signiﬁcantly different between the vitamin/no vitamin
groups were all non signiﬁcantly different after adjustment for
propensity score quintiles. However, even after selection bias
adjustment, vitamin usage continues to be non-signiﬁcant
(0.896, 0.594–1.352). CONCLUSIONS: Although, propensity
scores helped reduce potential sources of bias in this cross-sec-
tional database, they did not improve the ability to detect a rela-
tionship between vitamin usage and AMD. Other sources of bias,
such as the inability to determine the time of development of
AMD, unknown dosages and speciﬁc vitamins used, could not
be addressed by the use of propensity scores.
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OBJECTIVES: On-demand proton pump inhibitor (PPI) main-
tenance therapy is recommended for patients with symptomatic
gastroesophageal reﬂux disease (GERD) in Italy who achieve
symptom remission after 4 weeks of continuous treatment. The
objectives of this analysis are to evaluate the costs to the health
care system (NHS) and to society and effectiveness (quality
adjusted life years) of on-demand maintenance therapy in
patients with symptomatic GERD. METHODS: Decision analy-
sis and Markov modelling of costs and effectiveness up to 12
months. Efﬁcacy data were extracted from seven placebo-
controlled trials; the primary outcome measure was time to treat-
ment discontinuation owing to relapse of symptoms, requiring
continuous therapy. Health state utilities were derived from a
previously published study and data on health care resource util-
isation were obtained from a prospective Italian study that 
followed 577 patients with functional dyspepsia for one year.
RESULTS: Differences in utility scores associated with each PPI,
ranging from 0.731 to 0.745 quality-adjusted life years, were not
statistically different. Annual expected cost, however, were sta-
tistically different among the different drugs and the following
cost-minimization raking was obtained for costs to the NHS and
to society, respectively: rabeprazole (181€, 295€), pantoprazole
(223€, 341€), lansoprazole (249€, 370€), omeprazole 10mg
(297€, 412€), esomeprazole (295€, 419€), omeprazole 20mg
(405€, 528€). Unit cost of PPI was the major determinant of cost
to the NHS, while productivity days lost due to symptoms was
the major determinant of cost to society. CONCLUSIONS:
